Cyclopropanemethanamine → N-tert-Butyl-3-((4-(4-(3-(cyclopropylmethyl)ureido)-2-fluorobenzoyl)piperazin-1-yl)methyl)benzamide
반응식
Cl[C:2](OC1C=CC([N+]([O-])=O)=CC=1)=[O:3].[NH2:14][C:15]1[CH:42]=[CH:41][C:18]([C:19]([N:21]2[CH2:26][CH2:25][N:24]([CH2:27][C:28]3[CH:29]=[C:30]([CH:38]=[CH:39][CH:40]=3)[C:31]([NH:33][C:34]([CH3:37])([CH3:36])[CH3:35])=[O:32])[CH2:23][CH2:22]2)=[O:20])=[C:17]([F:43])[CH:16]=1.[CH:44]1([CH2:47][NH2:48])[CH2:46][CH2:45]1>C(#N)C>[C:34]([NH:33][C:31](=[O:32])[C:30]1[CH:38]=[CH:39][CH:40]=[C:28]([CH2:27][N:24]2[CH2:25][CH2:26][N:21]([C:19](=[O:20])[C:18]3[CH:41]=[CH:42][C:15]([NH:14][C:2]([NH:48][CH2:47][CH:44]4[CH2:46][CH2:45]4)=[O:3])=[CH:16][C:17]=3[F:43])[CH2:22][CH2:23]2)[CH:29]=1)([CH3:37])([CH3:36])[CH3:35]참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
4-Nitrophenyl chloroformate (59 mg, 0.29 mmol) was added to a solution of 3-((4-(4-amino-2-fluorobenzoyl)piperazin-1-yl)methyl)-N-tertbutylbenzamide (100 mg, 0.24 mmol) in acetonitrile (10 mL). After stirring at room temperature for 1 hour, cyclopropylmethylamine (126 μL, 1.21 mmol) was added. After 2 hours stirring, the reaction was purified by strong cation exchange chromatography, eluting macroporous polystyrene sulfonic acid with 2N ammonia in methanol. The resulting solution was concentrated under vacuum and purified by basic reverse phase HPLC to afford the title compound as a white solid (10 mg).
후처리
- stirringAfter 2 hours stirring
- customthe reaction was purified by strong cation exchange chromatography
- washeluting macroporous polystyrene sulfonic acid with 2N ammonia in methanol
- concentrationThe resulting solution was concentrated under vacuum
- custompurified by basic reverse phase HPLC
출처 및 근거
- ORD 기록
- ord-e3eb9176b36346c1a72d1df8eb0f5c65
- 출처 데이터셋
- uspto-grants-2012_11
- 특허 번호
- US08314091B2
반응 노트
불러오는 중…